-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RCXCgSSUbrkHjy+zMdYcdAdu33dge17bLKnYrfwJ92FFM9DvvX7NrxB4rdOIDKaH r8b97lhShRpnAIhA4lYLCQ== 0001072613-03-000580.txt : 20030408 0001072613-03-000580.hdr.sgml : 20030408 20030408155256 ACCESSION NUMBER: 0001072613-03-000580 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20030408 GROUP MEMBERS: GEORGE L. SING GROUP MEMBERS: LANCET CAPITAL HEALTH VENTURES G.P., LLC GROUP MEMBERS: WILLIAM J. GOLDEN FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: LANCET CAPITAL HEALTH VENTURES LP CENTRAL INDEX KEY: 0001226334 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 124 MT. AUBURN ST. CITY: CAMBRIDGE STATE: MA ZIP: 02138 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DYAX CORP CENTRAL INDEX KEY: 0000907562 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043053198 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-60267 FILM NUMBER: 03642759 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQ BLDG 600 5TH FL CITY: CAMBRIDGE STATE: MA ZIP: 02139 MAIL ADDRESS: STREET 1: ONE KENDALL SQ BLDG 600 STREET 2: 5TH FL CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: BIOTAGE INC DATE OF NAME CHANGE: 19951117 SC 13G 1 sc13g_11850.txt SCHEDULE 13G - LANCET CAPITAL HEALTH VENTURES LP ================================================================================ - -------------------------------------------------------------------------------- SEC 1745 POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF INFORMATION (6-00) CONTAINED IN THIS FORM ARE NOT REQUIRED TO RESPOND UNLESS THE FORM DISPLAYS A CURRENTLY VALID OMB CONTROL NUMBER. - -------------------------------------------------------------------------------- -------------------------- OMB APPROVAL -------------------------- OMB Number: 3235-0145 Expires: December 31, 2005 Estimated average burden hours per response. . . 11 -------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. __)* Dyax Corporation - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 26746E103 - -------------------------------------------------------------------------------- (CUSIP Number) March 14, 2003 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-1(c) [_] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). ================================================================================ ==================== ================= CUSIP No. 26746E103 13G Page 2 of 8 Pages ==================== ================= ================================================================================ 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS(ENTITIES ONLY). Lancet Capital Heath Ventures, L.P. (Tax ID: 043427577) - ---- -------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [_] - ---- -------------------------------------------------------------------------- 3. SEC USE ONLY - ---- -------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- 5. SOLE VOTING POWER 0 ---- ------------------------------------------------------- NUMBER OF 6. SHARED VOTING POWER SHARES BENEFICIALLY 1,344,087 OWNED BY ---- ------------------------------------------------------- EACH 7. SOLE DISPOSITIVE POWER REPORTING PERSON WITH 0 ---- ------------------------------------------------------- 8. SHARED DISPOSITIVE POWER 1,344,087 - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,344,087 - ---- -------------------------------------------------------------------------- 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [_] - ---- -------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.5% - ---- -------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON PN ================================================================================ ==================== ================= CUSIP No. 26746E103 13G Page 3 of 8 Pages ==================== ================= ================================================================================ 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS(ENTITIES ONLY). Lancet Capital Heath Ventures G.P., LLC (Tax ID: 043427574) - ---- -------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [_] - ---- -------------------------------------------------------------------------- 3. SEC USE ONLY - ---- -------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- 5. SOLE VOTING POWER 0 ---- ------------------------------------------------------- NUMBER OF 6. SHARED VOTING POWER SHARES BENEFICIALLY 1,344,087 OWNED BY ---- ------------------------------------------------------- EACH 7. SOLE DISPOSITIVE POWER REPORTING PERSON WITH 0 ---- ------------------------------------------------------- 8. SHARED DISPOSITIVE POWER 1,344,087 - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,344,087 - ---- -------------------------------------------------------------------------- 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [_] - ---- -------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.5% - ---- -------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON CO ================================================================================ ==================== ================= CUSIP No. 26746E103 13G Page 4 of 8 Pages ==================== ================= ================================================================================ 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS(ENTITIES ONLY). William J. Golden - ---- -------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [_] - ---- -------------------------------------------------------------------------- 3. SEC USE ONLY - ---- -------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 5. SOLE VOTING POWER 0 ---- ------------------------------------------------------- NUMBER OF 6. SHARED VOTING POWER SHARES BENEFICIALLY 1,344,087 OWNED BY ---- ------------------------------------------------------- EACH 7. SOLE DISPOSITIVE POWER REPORTING PERSON WITH 0 ---- ------------------------------------------------------- 8. SHARED DISPOSITIVE POWER 1,344,087 - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,344,087 - ---- -------------------------------------------------------------------------- 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [_] - ---- -------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.5% - ---- -------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON IN ================================================================================ ==================== ================= CUSIP No. 26746E103 13G Page 5 of 8 Pages ==================== ================= ================================================================================ 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS(ENTITIES ONLY). George L. Sing - ---- -------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [_] - ---- -------------------------------------------------------------------------- 3. SEC USE ONLY - ---- -------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 5. SOLE VOTING POWER 0 ---- ------------------------------------------------------- NUMBER OF 6. SHARED VOTING POWER SHARES BENEFICIALLY 1,344,087 OWNED BY ---- ------------------------------------------------------- EACH 7. SOLE DISPOSITIVE POWER REPORTING PERSON WITH 0 ---- ------------------------------------------------------- 8. SHARED DISPOSITIVE POWER 1,344,087 - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,344,087 - ---- -------------------------------------------------------------------------- 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [_] - ---- -------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.5% - ---- -------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON IN ================================================================================ ==================== ================= CUSIP No. 26746E103 13G Page 6 of 8 Pages ==================== ================= ITEM 1.(A) NAME OF ISSUER Dyax Corporation ITEM 1.(B) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES 300 Technology Square Cambridge, MA 02139 ITEM 2.(A) NAME OF PERSONS FILING This filing is made on behalf of each of Lancet Capital Health Ventures, L.P., Lancet Capital Health Ventures, G.P., LLC, William J. Golden, and George L. Sing. ITEM 2.(B) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE The principal business office of each reporting person is 124 Mount Auburn Street, Suite 200N, Cambridge, Massachusetts 02138. ITEM 2.(C) CITIZENSHIP Lancet Capital Health Ventures, L.P. and Lancet Capital Health Ventures, G.P., LLC are organized and exist under the laws of the State of Delaware. Golden and L. Sing are United States citizens. ITEM 2.(D) TITLE OF CLASS OF SECURITIES Common Stock, $.01 par value per share. ITEM 2.(E) CUSIP NUMBER 26746E103 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TOSS.SS.240.13D-1(B) OR 240.13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A: N/A ==================== ================= CUSIP No. 26746E103 13G Page 7 of 8 Pages ==================== ================= ITEM 4. OWNERSHIP. The information contained in Items 5-11 of the cover page is incorporated herein by reference. Lancet Capital Health Ventures, L.P. ("Lancet Capital L.P."), is the record owner of the shares of common stock. Lancet Capital Health Ventures, G.P., LLC ("Lancet Capital G.P."), in its capacity as general partner of Lancet Capital L.P., has the power to vote and dispose of the common stock held by Lancet Capital L.P. Golden and Sing are the managing directors of Lancet Capital G.P. As such, they each have the power to direct the voting control of Lancet Capital G.P. While neither Golden nor Sing own of record any shares of common stock, as a result of their positions, Golden and Sing may be deemed to be beneficial owners of and to have the power to exercise or to direct the exercise of voting and/or dispositive power with respect to the shares reported herein. Messrs. Golden and Sing disclaim beneficial ownership over any of the reported securities which they may be been deemed to beneficially own. ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS N/A ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. N/A ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY N/A ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP N/A ITEM 9. NOTICE OF DISSOLUTION OF GROUP N/A ITEM 10. CERTIFICATION By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. ==================== ================= CUSIP No. 26746E103 13G Page 8 of 8 Pages ==================== ================= SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. April 4, 2003 LANCET CAPITAL HEALTH VENTURES, L.P. By: Lancet Capital Health Ventures G.P., LLC By: /s/ William J. Golden -------------------------------- Name: William J. Golden ----------------------------- Title: Managing Director ---------------------------- April 4, 2003 LANCET CAPITAL HEALTH VENTURES G.P., LLC By: /s/ William J. Golden -------------------------------- Name: William J. Golden ----------------------------- Title: Managing Director ---------------------------- WILLIAM J. GOLDEN April 4, 2003 /s/ William J. Golden ----------------------------------- Name: William J. Golden ----------------------------- GEORGE L. SING April 4, 2003 /s/ George L. Sing ----------------------------------- Name: George L. Sing ----------------------------- JOINT FILING AGREEMENT Lancet Capital Health Ventures, L.P., Lancet Capital Health Ventures, G.P., LLC, William J. Golden, and George L. Sing agree that the Schedule 13G, to which this Agreement is attached, relating to the common stock of Dyax Corporation, is filed on behalf of each of them. Dated: April 4, 2003 LANCET CAPITAL HEALTH VENTURES, L.P. By: Lancet Capital Health Ventures G.P., LLC By: /s/ William J. Golden -------------------------------- Name: William J. Golden ----------------------------- Title: Managing Director ---------------------------- Dated: April 4, 2003 LANCET CAPITAL HEALTH VENTURES G.P., LLC By: /s/ William J. Golden -------------------------------- Name: William J. Golden ----------------------------- Title: Managing Director ---------------------------- WILLIAM J. GOLDEN Dated: April 4, 2003 /s/ William J. Golden ----------------------------------- Name: William J. Golden ----------------------------- GEORGE L. SING Dated: April 4, 2003 /s/ George L. Sing ----------------------------------- Name: George L. Sing ----------------------------- -----END PRIVACY-ENHANCED MESSAGE-----